Next Article in Journal
Morphological, Molecular and Metabolic Characterization of the Pigmented Fungus Subramaniula asteroids
Previous Article in Journal
Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action

by
Ellen A. Malveira
1,
Pedro F. N. Souza
1,2,*,
Nilton A. S. Neto
1,
Tawanny K. B. Aguiar
1,
Natanael S. Rodrigues
3,
Carlos W. B. Henrique
3,
Ayrles F. B. Silva
1,
Leandro B. Lima
4,
Cynthia C. Albuquerque
3 and
Cleverson D. T. Freitas
1,*
1
Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza 60020-181, Brazil
2
Drug Research and Development Center, Department of Physiology and Pharmacology, Federal University of Ceará, Fortaleza 60430-160, Brazil
3
Department of Biological Sciences, Faculty of Exact and Natural Sciences, State University of Rio Grande do Norte, Mossoró 59650-000, Brazil
4
Department of Chemistry, Faculty of Exact and Natural Sciences, State University of Rio Grande do Norte, Mossoró 59650-000, Brazil
*
Authors to whom correspondence should be addressed.
J. Fungi 2022, 8(11), 1147; https://doi.org/10.3390/jof8111147
Submission received: 1 October 2022 / Revised: 26 October 2022 / Accepted: 27 October 2022 / Published: 29 October 2022
(This article belongs to the Section Fungal Pathogenesis and Disease Control)

Abstract

:
Antimicrobial drugs are becoming ineffective given the resistance acquired by microorganisms. As such, it is imperative to seek new antimicrobial molecules that could provide a basis for the development of new drugs. Therefore, this work aimed to evaluate the antimicrobial potential and the mechanisms of action of the essential oil extracted from leaves of Croton blanchetianus (named CbEO) on different fungi and bacteria of clinical importance in both planktonic and biofilm lifestyles. GC-MS/MS analysis revealed the presence of twenty-two different compounds in the CbEO, which were identified using the Kovats retention index. Among these, the most abundant were amorphene (20.03%), spathulenol (5%), bicyclogermacrene (1.49%), caryophyllene oxide (4.55%), and eucalyptol (5.62%). CbOE (50 µg mL−1) barely inhibited the growth of Bacillus subtilis (23%), Pseudomonas aeruginosa (27%), and Salmonella enterica (28%), and no inhibition was obtained against Enterobacter aerogenes and Klebsiella pneumoniae. Additionally, no activity against bacterial biofilm was detected. In contrast, CbEO was active against Candida species. C. albicans and C. parapsilosis were inhibited by 78 and 75%, respectively. The antibiofilm potential also was favorable against C. albicans and C. parapsilosis, inhibiting 44 and 74% of biofilm formation and reducing around 41 and 27% of the preformed biofilm, respectively. CbOE caused membrane damage and pore formation, overproduction of ROS, and apoptosis on C. albicans and C. parapsilosis cells, as well as not inducing hemolysis in human red cells. The results obtained in this work raise the possibility of using the essential oil of C. blanchetianus leaves as an alternative to fight infections caused by C. albicans and C. parapsilosis.

1. Introduction

The misuse of antimicrobial drugs has dramatically intensified, generating a huge concern in health systems because of the emergence of multidrug-resistant pathogens, affecting around 5 million people worldwide [1]. Such conditions have driven humanity to an era referred to as post-antibiotic, making infections stronger and antibiotics useless [2]. For instance, infections caused by drug-resistant human pathogenic yeasts from the Candida genus, which affects healthy and immunocompromised people, are hard to treat. These infections range from superficial candidiasis localized on the skin to systemic and invasive bloodstream infections [3,4].
In addition, the formation of biofilms is another factor that enhance resistance of microorganisms to drugs [5]. Biofilm cells show differences in morphology, physiology, and gene expression compared to the planktonic form [6]. Moreover, they can be resistant to UV exposure, phagocytosis, and dehydration [7]. Thereby, drug-resistant microorganisms and their biofilms are problems that requires urgent attention and efforts to find new molecules to fight them back.
One of the alternatives for minimizing these problems is the search for new natural molecules, such as secondary metabolites produced by plants, which can inhibit the growth of resistant pathogens [8]. The Brazilian biomes are rich in many medicinal plants acting as biological sources for new molecules with therapeutic potential. Aromatic plants produce essential oils (EOs), defined as volatile and with strong odor characteristic, can be extracted from the leaves, barks, seeds, and fruits. In addition, some plant essential oils have been used to overcome microbial resistance [9,10].
C. blanchetianus (Figure 1) Baill is an oil-producing plant belonging to the Euphorbiaceae family that have plants with several medicinal properties [11]. It has antibacterial, anti-inflammatory, and gastroprotective actions [9,10]. For instance, Melo et al. [9] reported that the essential oil from C. blanchetianus has a potent antibacterial activity against Aeromonas hydrophila, Listeria monocytogenes, and Salmonella enteritidis [9]. Additionally, oil of C. blanchetianus applied on meat was shown to prevent the growth of the foodborne pathogen S. enteritidis, thus showing the potential application of the oil in industry. Works with the essential oil from C. blanchetianus on planktonic and biofilm cells of bacteria and fungi of clinical importance and its respective mechanisms of action are still scarce. Based on the application of essential oil from C. blanchetianus, we hypothesized that the oil could have application against human pathogens. Therefore, this work aims to characterize and evaluate the antimicrobial and antibiofilm potential of the essential oil from C. blanchetianus leaves (CbEO), as well as its mechanisms of action.

2. Results and Discussion

2.1. GC-MS/MS Analysis

Gas chromatography coupled with mass spectrometer (GC-MS/MS) revealed the presence of twenty-two different compounds in CbEO (Table 1). Among these, the most abundant were amorphene (20.03%), spathulenol (5.81%), bicyclogermacrene (1.49%), caryophyllene oxide (4.55%), and eucalyptol (5.62%). Almost all the compounds found in CbEO have been reported to present some biological activity. Although amorphene is the most abundant compound in the CbEO (Table 1), to date, it has not been related to antimicrobial or antifungal activity. Usually, the biological activities attributed to amorphene are antioxidant and anti-leishmanial activity [12,13,14]. However, other abundant compounds have been associated with antimicrobial activity. For instance, spathulenol displays antifungal and antibacterial activities [12], bicyclogermacrene possesses antifungal and antioxidant activities [13], caryophyllene oxide has been reported to possess antioxidant, anticancer, and antimicrobial properties [14], and eucalyptol presents anticandidal activity [15].
In addition to these most abundant compounds, other components (Table 1) detected in CbEO have also been reported with respect to their antimicrobial activity, such as limonene, borneol, α-terpineol, and sativene, presenting, respectively, anticandidal, antibacterial, and antifungal activities [15,16,17,18,19,20]. Furthermore, proteomic analysis of C. albicans cells treated with limonene revealed an up-accumulation of proteins involved with oxidative stress, DNA damage, nucleolar stress, and apoptosis [16].

2.2. Antimicrobial Activity

CbOE was tested against several human-pathogenic bacteria and yeasts (Table 2). The antibacterial activity of CbOE barely inhibited the growth of Bacillus subtilis (23%), Pseudomonas aeruginosa (27%), and Salmonella enterica (28%), and no inhibition was observed against Enterobacter aerogenes and Klebsiella pneumoniae, even using the highest concentration tested (50 µg mL−1). Likewise, no activity against the bacterial biofilms was detected at 50 µg mL−1 (Table 2). In a previous study [21], it was shown that the aromadendrene present in the EO of Eucalyptus globulus has remarkable activity on strains of methicillin-resistant S. aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VRE), and Acinetobacter baumanii. However, the inefficiency of CbEO against bacteria can be explained by the low concentration of potent antibacterial molecules, such as borneol, α-terpineol, and sativene found in other essential oils [15,16,17,18,19,20].
Regarding anticandidal activity, CbEO presented better results against C. albicans and C. parapsilosis, with inhibition of 78 and 75%, respectively, at 50 µg mL−1 (Table 2). Otherwise, C. krusei was barely susceptible (9.5% of inhibition) and C. tropicalis was not affected by treatment with CbEO even at the highest concentration tested (50 µg mL−1). The antibiofilm potential of CbOE (50 µg mL−1) was also favorable against C. albicans and C. parapsilosis, inhibiting 44 and 74% of biofilm formation and reducing preformed biofilm by 41 and 27%, respectively (Table 2). These results are in agreement with higher concentrations of spathulenol, bicyclogermacrene, caryophyllene oxide, and eucalyptol, which have been described as potent antifungal and anticandidal compounds [12,13,14,15]. Keymaram et al. [22] showed in their study that eucalyptol possesses antibiofilm activity against C. albicans at concentrations ranging from 125 to 8000 μg mL−1. Although detected at a low concentration in CbEO, limonene could also contribute to anticandidal activity, specifically against C. albicans, since this compound has already shown anticandidal activity [16]. Al-Ghanayem [23] showed that lemongrass leaf oil (Cymbopogon flexuosus) was active against C. albicans planktonic cells, and complete biofilm reduction could be observed at 0.5 μL mL−1 and 30% at a concentration of 0.03 μL mL−1.
In another study, the Pistachio hull essential oil completely inhibited the growth of C. parapsilosis at a concentration of 2.50 mg mL−1 and slightly inhibited C. glabrata and C. albicans at the same concentration [24]. It seems that the results presented by CbEO are exciting when compared to those above. Compared to D’Arrigo et al. [24], EO was effective against C. parapsilosis at a concentration 50 times lower than that required for essential oil from Pistachio hull. In addition, CbEO was also effective against C. parapsilosis biofilm (Table 2). Natural products are considered strong inhibitors when they have an MIC50 of up to 0.5 mg mL−1, moderate inhibitors between 0.6 and 1.5, and weak inhibitors when this value is higher than 1.6 mg mL−1 (Madeira et al., 2016). Corroborating this work, CbEO is considered a strong inhibitor of C. albicans and C. parapsilosis, since it shows activity at 0.05 mg mL−1 (Table 2).
C. citrate oil with silicone rubber coating inhibited C. tropicalis biofilm formation by between 45 and 76% [25]. Here, our results revealed that CbEO was not effective against C. tropicalis. This, indeed, is not a negative result. However, it is an interesting result because shows selectivity. The literature has already discussed that different essential oils may present distinct biological activities based on their composition [23]. The activity of CbEO against C. albicans and C. parapsilosis biofilms has a great potential to drive further studies to develop new drugs against biofilms. As already mentioned, biofilm formation is one of the mechanisms of fungal resistance occasioned by Candida species that may be associated with medical devices such as cardiovascular, venous, and urinary catheters [26].

2.3. Mechanisms of Action

2.3.1. Membrane Damage and Pore Formation

There are other studies evaluating the anticandidal activity of essential oils from many plants. However, few have shown the mechanism of action. Thakre et al. [16] revealed by proteomic analysis the up accumulation of proteins related to damage to DNA and nucleolar region, suggesting induction of apoptosis in C. albicans cells treated with limonene. Recently, Yu et al. [19] reported that limonene induced mitochondrial membrane depolarization and cell membrane pore formation.
Here, we provide evidence about how the CbEO displays anticandidal activity. The propidium iodide (PI) uptake assay was employed to evaluate the membrane damage in C. albicans and C. parapsilosis planktonic and biofilm cells. PI interacts with DNA, releasing red fluorescence. However, it can only move through damaged membrane, thus indicating pore formation. Therefore, healthy membranes do not allow the passage of PI through them. The data obtained regarding the planktonic cells showed no fluorescence of PI on control (5% DMSO) cells (Figure 2). In contrast, C. albicans and C. parapsilosis cells treated with CbEO showed red fluorescence, indicating membrane damage (Figure 2). The fluorescence was quantified and showed that C. parapsilosis cells were more susceptible to membrane damage caused by CbEO than C. albicans (Figure 2). Similarly, CbEO was also able to induce membrane permeabilization in both C. albicans and C. parapsilosis biofilms (Figure 3). Indeed, CbEO was more efficient against C. albicans biofilms than in planktonic cells (Figure 3). The membrane damage induced by essential oils from plants has already been discussed [27]. However, there are no studies indicating the size of the pore formed.
Although PI indicates damage to the cell membrane, it does not give any information about pore size. Thus, new assays were performed using a fluorophore with a size of 6 kDa (Dextran-FITC). Only C. parapsilosis planktonic cells showed green fluorescence, indicating that CbEO allowed the movement of 6 kDa FITC-dextran (Figure 3). In contrast, green fluorescence was observed in biofilm cells of both C. albicans and C. parapsilosis (Figure 2). Etxaniz et al. [28] revealed that in some cases, the cell membrane can recover from the formation of a pore. For example, the pores revealed by PI have a size of around 0.1 nm, making it possible for the cell to recover. However, pores revealed by FITC-Dextran have a size of 1.0 nm, and are thus classified as large pores, making it quite difficult for the cells to recover [28], since there may be extravasation of various cellular molecules, membrane depolarization, and induction of apoptosis, as reported by Thakre et al. [16].
The Zanthoxylum schinifolium essential oil had activity on membrane permeabilization against the fungus Malassezia restricta [29]. Terpenoids have already been reported to alter membrane fluidity and modulation of proteins linked to signaling and transport [30]. In a previous study [31], it was shown that terpinen-4-ol can impair the integrity and physiology of fungal cells by inducing membrane loss.

2.3.2. Overproduction of Reactive Oxygen Species (ROS)

To further explore the mechanism of action, the ROS overproduction induced by CbEO in both C. albicans and C. parapsilosis cells was evaluated. The CbEO (50 µg mL−1) induced ROS overproduction (Figure 4) in planktonic cells of both yeasts (green fluorescence). However, there was a difference in the intensity of ROS produced by both species. The quantification of fluorescence revealed a higher amount of ROS produced by C. parapsilosis (Figure 4). As expected, the controls did not have an overproduction of ROS. CbEO also induced ROS overproduction in biofilms of both C. parapsilosis and C. albicans (Figure 5—white arrows), albeit to a lesser extent.
Ding et al. [32] reported that ROS levels increased in C. albicans cells after incubation with a quinoline compound. Yang et al. [33] showed that lavender essential oil induced oxidative stress in K. pneumonia, leading to membrane permeabilization and cell death. Indeed, the high level of ROS could be lethal to cells because it can lead to damage to critical molecules such as DNA, protein, and lipids [34]. Looking the composition of lavender essential [33], the presence of limonene, borneol, and caryophyllene was also present in CbEO. These compounds, present in both oils, could be involved in ROS overproduction in microbial cells. ROS is essential to biofilm biogenesis, development, and formation, as well as the genetic variability of cells [35]. However, the line between benefits and lethal effects is thin and easy to cross. A slight imbalance of ROS levels can lead to its accumulation, which is lethal, because it inactivates vital molecules such as carbohydrates, nucleic acids, proteins, and lipids, triggering programmed cell death [36].

2.3.3. Caspase 3/7-Mediated Apoptosis

CbEO induced caspase 3/7-mediated apoptosis in planktonic cells of C. albicans and C. parapsilosis and weakly in biofilms of C. albicans only (Figure 6 and Figure 7). The exact mechanism of how CbEO induced apoptosis in the C. parapsilosis cells has not yet been elucidated. Caspase-3/7 starts apoptotic DNA fragmentation by activating of a protein called DNA fragmentation factor-45 (DFF45) and an inhibitor of caspase-activated DNase (ICAD). Thakre et al. [16] revealed by proteomic analysis that the treatment with limonene increase the accumulation of proteins involved with DNA damage and apoptosis in C. albicans cells. However, as happens here, the authors did not understand the mechanism involved.

2.3.4. Scanning Electron Microscopy (SEM)

SEM was also used to evaluate the damage on C. albicans and C. parapsilosis cells caused (Figure 8) after treatment with CbEO (50 µg mL−1). CbEO caused changes in the morphology of cells, scars, roughness, and depletions leading to loss of internal content corroborating with the data from fluorescent microscopy. In contrast, control cells did not present any damage (Figure 8). The SEM analysis provided important results, because there were not many works evaluating the cellular damage caused by EOs in yeast cells.

2.3.5. Hemolytic Activity

To be considered as potential molecules for the development of new drugs, the candidate should not present any or very low toxicity to hosts [37]. Based on the data obtained, CbEO does not show toxicity to blood types A, B and O, even at the highest concentration tested (250 µg mL−1), when compared to the control (DMSO 5%) (Table 3).

3. Conclusions

This study highlights relevant results about the potential of CbEO as a source of anticandida molecules. These data are essential for understanding the possible application of CbEO in treating infections caused by C. albicans and C. parapsilosis. A future perspective is essential to notice that CbEO is not toxic to human red blood cells, which, together with anticandidal activity, opens up great prospects for its application in the future. The main conclusion is that CbEO possesses potent anticandida activity in both planktonic and biofilm lifestyles and presents no danger to human red blood cells.

4. Experimental Section

4.1. Biological Material

The leaves of Croton blanchethianus Baill. were collected in the city of Mossoró, Rio Grande do Norte, Brazil (latitude: −5.201324, longitude: −37.320572). Regarding microorganisms, the yeasts C. albicans (ATCC 10231), C. krusei (ATCC 6258), C. parapsilosis (ATCC 22019), Cryptococcus neoformans (ATCC 32045) and C. tropicalis (Clinical isolate) and the bacteria B. subtilis (ATCC 6633), E. aerogenes (ATCC 13048), K. pneumoniae (ATCC 10031), P. aeruginosa (ATCC 25619), and S. enterica (ATCC 14028) were obtained of the Laboratory of Plant Toxins of the Federal University of Ceará, Brazil.

4.2. Oil Extraction

The original equipment was provided by the Laboratory of Plant Physiology and Biochemistry (LFBP). For the extraction process, the methodology proposed by Oliveira et al. was followed [38]. We decided to use the leaves because they have the largest amount of glandular trichomes, for the storage and synthesis of bioactive metabolites such as the terpenoids and flavonoids that are present. The essential oil from the leaves of C. blanchethianus (CbEO) was extracted by the hydrodistillation method using a Clevenger apparatus. In the Clevenger apparatus, samples are diluted in water, which is boiled to evaporate volatile components in the steam. In this way, two layers (aqueous and oil-rich) are obtained, and oil is separated using separating funnels. For extraction, the leaves were weighed (586 g) on a precision balance and then placed in a volumetric flask containing 2 L of distilled water. The flask was attached and heated on a heating mantle. After boiling, the steam generated was condensed, and oil and water were collected in a Dean–Stark apparatus. As they are immiscible, two phases were formed, and it was possible to separate oil and water. The oil was extracted for a period of 2 h, controlling the temperature to approximately 100 °C. The essential oil was dehydrated 6 g of anhydrous sodium sulfate (PM:142.04) and 10 mL of ethyl ether, resulting 8 mL of oil, which was stored under refrigeration (4 °C).

4.3. Characterization of CbEO by GC-MS/MS Analysis

The chemical composition of CbEO was examined by gas chromatography coupled with mass spectrometry (GC-MS/MS) (Shimadzu GCMS-QP2010 SE, Kyoto, Japan), which was equipped with an Rtx®-5MS capillary column (30 m × 0.25 mm × 0.25 μm). The operating conditions of the GC-MS/MS were optimized as follows: 70 eV, carrier gas (He), flow rate of 1.7 mL.min−1, and pressure 53.5 KPa. The temperatures of the injector and the interface of the detector were 25 °C and 230 °C, respectively. The oven temperature program was 100 °C for 3 min, and then 310 °C at a heating rate of 3.5 °C/min and maintained at 310 °C for 5 min. The identification of the constituents of the essential oils was investigated by comparing the mass spectra and Kovats index values (IK) with those of the library search references.

4.4. Antimicrobial and Antibiofilm Activities

The anticandidal activity was evaluated using the microdilution method described by the Clinical and Laboratory Standards Institute [39] with some modifications. To evaluate cell growth inhibition, an aliquot (50 µL) of yeast cell suspensions (0.5–2.5 × 106 CFU mL−1) in Saboraud liquid medium was mixed in 96-well plates with 50 µL of CbEO (ranging from 50 to 0.008 µg mL−1, diluted in 5% DMSO).
The antibacterial activity was determined according to the method described by Oliveira et al. [40] with modifications. The experimental assay was similar to the previous one, with the bacterial cells being cultivated in Mueller–Hinton Broth medium. The positive controls were nystatin and ciprofloxacin and the negative control was 5% DMSO. After 24 h at 37 °C, the cell growth was measured using a microplate reader at 600 nm (Epoch, BioTek Instruments Inc., Winooski, VT, USA). Each experiment was performed three times, with three replicates per treatment.
The antibiofilm assays were performed according to the method described by Dias et al. [41]. The same controls and concentrations of CbEO used in planktonic cells were applied in the biofilm assays. After 24 h of incubation, the supernatant was removed from the wells, followed by three washes with 0.15 M NaCl, and then 200 μL of methyl alcohol was added to each well for 15 min to allow fixation of the adhered cells to occur. Then, 200 μL of 0.1% crystal violet was added for another 15 min. To dissolve the dye attached to the biofilm, 200 μL of 33% acetic acid was added and left on the plate for reading the absorbance at 590 nm using a plate reader.

4.5. Mechanisms of Action

4.5.1. Membrane Damage

For cell membrane integrity assay, 50 µL of C. albicans or C. parapsilosis cell suspension (2.5 × 103 CFUmL−1, in Saboraud liquid medium) was mixed with 50 µL of CbEO (50 µg mL−1) and incubated for 24 h at 37 °C. Then, the samples were centrifuged at 5000× g for 5 min at 4 °C, and the cells were washed three times with 100 µL of 0.15 M NaCl. Subsequently, 50 µL of NaCl and 3 µL of 1 mM propidium iodide (PI) were added and the mixture was incubated for 30 min in the dark at 37 °C. Afterward, the samples were washed twice with 0.15 M NaCl to remove excess PI and the cells were resuspended in 50 µL of 0.15 M NaCl to be analyzed on a fluorescence microscope (Olympus System BX 41, Tokyo, Japan) with an excitation wavelength of 535 nm and emission wavelength of 617 nm.
Additionally, the samples were treated similarly to the previous analysis and incubated with 3 µL of 1 mM 6 kDa FITC-Dextran (Sigma Aldrich, Sao Paulo, Brazil) in the dark for 30 min, according to Oliveira et al. [40]. The result was observed under a fluorescence microscope (Olympus System BX60) with an excitation wavelength of 488 nm and an emission wavelength of 525 nm.

4.5.2. Induction of Reactive Oxygen Species (ROS)

To perform ROS overproduction, the methodology described by Dikalov and Harrison [42] was followed. The experimental design was similar to the previous assays of antimicrobial activity. First 50 µL of C. albicans or C. parapsilosis cell suspension (2.5 × 106 CFU mL−1, in Saboraud liquid medium) was mixed with 50 µL of CbEO (50 µg mL−1) and incubated for 24 h at 37 °C. The samples were washed three times with 0.15 M NaCl solution and incubated with 50 µL of 0.2 M DCFH-DA for 20 min in the dark. A fluorescence microscope (Olympus System BX60) was used with an excitation wavelength of 485 nm and an emission wavelength of 538 nm.

4.5.3. Induction of Apoptosis

The caspase activity was measured after cell incubation for 24 h, in the presence and absence of essential oil, according to the manufacturer’s instructions. The cells were treated as above and then incubated using 3 μL of 2 mM CellEvent® reagent (ThermoFisher, São Paulo, SP, Brazil) for 30 min in the dark. Then, cells were washed and centrifuged as described above. Finally, the cells were observed under a fluorescence microscope (Olympus System BX60) at an excitation wavelength of 342 nm and an emission wavelength of 441 nm.

4.6. Scanning Electron Microscopy (SEM)

For SEM analysis, the samples were mixed under the same conditions described previously, and then glutaraldehyde in 0.15 M sodium phosphate buffer pH 7.2 was added for 16 h at 25 °C for fixation. After that, each sample was washed three times with 0.15 M sodium phosphate buffer pH 7.2. For dehydration, it was washed with ethanol at different concentrations (30, 50, 70, and 100%) leaving it for 10 min, except for the last concentration, which was dehydrated twice for 10 min. Subsequently, 50% hexamethyldisilane (HMDS, Sigma, St. Louis, MI, USA) was diluted in ethanol for 10 min and then 100% HMDS was added. A 15 µL aliquot was added to coverslips and made it possible to dry at room temperature. For observation of the cells, they were coated with gold on aluminum surfaces and observed under a scanning electron microscope (Everhart–Thornley) [43].

4.7. Hemolytic Activity

The hemolytic activity of CbEO was tested against red blood cells (A, B and O+) according to Oliveira et al. [40]. Blood types were provided by the Center for Hematology and Hemotherapy of Ceará (Brazil). Cells were centrifuged at 5000× g for 5 min at 4 °C, and dissolved in 0.15 M NaCl. Six washes were performed, and then the bloods were diluted to 2.5% in 0.15 M NaCl. Subsequently, an aliquot of 300 μL of each blood type was incubated with 300 μL of CbOE at concentrations ranging from 50 to 12.5 μg mL−1, while the negative control contained 5% DMSO and the positive control 0.1% (v/v) Triton X-100. Then, the samples were incubated for 30 min at 37 °C, followed by centrifugation (5000× g for 5 min at 4 °C). After that, the supernatants were collected and transferred to 96-well plates. Hemolysis (%) was calculated by measuring the absorbance of the supernatant at 414 nm using a microplate reader.

4.8. Statistical Analysis

All tests were performed in three biologically independent experiments. The difference between the means of the triplicates was verified by applying the ANOVA test followed by the Tukey method using the GraphPad Prism program version 5.01 (GraphPad Software company, Santa Clara, CA, USA). Values of p < 0.05 were considered statistically significant.

Author Contributions

All authors made substantial contributions. The Conceptualization was performed by E.A.M., P.F.N.S., N.A.S.N., T.K.B.A., N.S.R., C.W.B.H., A.F.B.S., L.B.L., C.C.A. and C.D.T.F.; methodology was carried out by E.A.M., P.F.N.S., N.A.S.N., T.K.B.A., N.S.R., C.W.B.H., A.F.B.S., L.B.L., C.C.A. and C.D.T.F.; validation was carried out by E.A.M., N.A.S.N., P.F.N.S., and T.K.B.A.; formal analysis was carried out by E.A.M., C.D.T.F. and P.F.N.S.; investigation was carried out by E.A.M., C.D.T.F., C.C.A. and P.F.N.S.; resources was carried out by C.D.T.F. and P.F.N.S.; data curation was carried out by E.A.M., C.D.T.F. and P.F.N.S.; visualization was carried out by C.D.T.F. and P.F.N.S.; supervision was carried out by C.D.T.F. and P.F.N.S.; project was carried out by C.D.T.F. and P.F.N.S.; writing—original draft preparation was done by E.A.M., T.K.B.A., C.D.T.F. and P.F.N.S.; writing—review and editing by P.F.N.S. All authors have read and agreed to the published version of the manuscript.

Funding

Special thanks to CAPES for providing the postdoctoral grant to Pedro F.N. Souza (grant number 88887.318820/2019-00). We are also grateful to the staff of the central analytical facilities of UFC, Brazil.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data supporting this study’s findings are available on request from the corresponding author.

Conflicts of Interest

The authors report no conflict of interest. The authors alone are responsible for the content and the writing of the paper.

References

  1. Murray, C.J.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Robles Aguilar, G.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef]
  2. WHO. Antimicrobial Resistance; Global Report on Surveillance; Bulletin of the World Health Organization: Geneva, Switzerland, 2014; Volume 61, pp. 383–394. [Google Scholar]
  3. López-Martínez, R. Candidosis, a New Challenge. Clin. Dermatol. 2010, 28, 178–184. [Google Scholar] [CrossRef] [PubMed]
  4. Papon, N.; Courdavault, V.; Clastre, M.; Bennett, R.J. Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm. PLoS Pathog. 2013, 9, e1003550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Do Vale, J.P.C.; Ribeiro, L.H.d.F.; de Vasconcelos, M.A.; Sá-Firmino, N.C.; Pereira, A.L.; do Nascimento, M.F.; Rodrigues, T.H.S.; da Silva, P.T.; de Sousa, K.C.; da Silva, R.B.; et al. Chemical Composition, Antioxidant, Antimicrobial and Antibiofilm Activities of Vitex gardneriana Schauer Leaves’s Essential Oil. Microb. Pathog. 2019, 135, 103608. [Google Scholar] [CrossRef] [PubMed]
  6. Olivares, E.; Badel-Berchoux, S.; Provot, C.; Prévost, G.; Bernardi, T.; Jehl, F. Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections. Front. Microbiol. 2020, 10. [Google Scholar] [CrossRef]
  7. Gupta, P.; Sarkar, S.; Das, B.; Bhattacharjee, S.; Tribedi, P. Biofilm, Pathogenesis and Prevention—A Journey to Break the Wall: A Review. Arch. Microbiol. 2016, 198, 1–15. [Google Scholar] [CrossRef]
  8. Mathur, S.; Hoskins, C. Drug Development: Lessons from Nature. Biomed. Rep. 2017, 6, 612–614. [Google Scholar] [CrossRef] [Green Version]
  9. Melo, G.F.d.A.; da Costa, A.C.V.; Garino, F., Jr.; Medeiros, R.S.; Madruga, M.S.; Neto, V.Q. The sensitivity of bacterial foodborne pathogens to Croton blanchetianus Baill essential oil. Braz. J. Microbiol. 2013, 44, 1189–1194. [Google Scholar] [CrossRef] [Green Version]
  10. Aquino, V.V.F.; Costa, J.G.M.; Angélico, E.C.; Medeiros, R.S.; Lucena, M.d.A.; Rodrigues, O.G. Metabólitos secundários e ação antioxidante de Croton heliotripifolius e Croton blanchetianus. Acta Bras. 2017, 1, 28–31. [Google Scholar] [CrossRef] [Green Version]
  11. Freitas, A.F.S.; Costa, W.K.; Machado, J.C.B.; Ferreira, M.R.A.; Paiva, P.M.G.; Medeiros, P.L.; Soares, L.A.L.; Oliveira, A.M.; Napoleão, T.H. Toxicity Assessment and Antinociceptive Activity of an Ethanolic Extract from Croton blanchetianus (Euphorbiaceae) Leaves. South Afr. J. Bot. 2020, 133, 30–39. [Google Scholar] [CrossRef]
  12. Cazella, L.N.; Glamoclija, J.; Soković, M.; Gonçalves, J.E.; Linde, G.A.; Colauto, N.B.; Gazim, Z.C. Antimicrobial Activity of Essential Oil of Baccharis dracunculifolia DC (Asteraceae) Aerial Parts at Flowering Period. Front. Plant Sci. 2019, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Nogueira Sobrinho, A.C.; de Morais, S.M.; Marinho, M.M.; de Souza, N.V.; Lima, D.M. Antiviral Activity on the Zika Virus and Larvicidal Activity on the Aedes Spp. of Lippia alba Essential Oil and β-Caryophyllene. Ind. Crops Prod. 2021, 162, 113281. [Google Scholar] [CrossRef]
  14. Dahham, S.; Tabana, Y.; Iqbal, M.; Ahamed, M.; Ezzat, M.; Majid, A.; Majid, A. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna. Molecules 2015, 20, 11808–11829. [Google Scholar] [CrossRef] [PubMed]
  15. Ivanov, M.; Kannan, A.; Stojković, D.S.; Glamočlija, J.; Calhelha, R.C.; Ferreira, I.C.F.R.; Sanglard, D.; Soković, M. Flavones, Flavonols, and Glycosylated Derivatives—Impact on Candida albicans Growth and Virulence, Expression of CDR1 and ERG11, Cytotoxicity. Pharmaceuticals 2020, 14, 27. [Google Scholar] [CrossRef]
  16. Thakre, A.; Zore, G.; Kodgire, S.; Kazi, R.; Mulange, S.; Patil, R.; Shelar, A.; Santhakumari, B.; Kulkarni, M.; Kharat, K.; et al. Limonene Inhibits Candida albicans Growth by Inducing Apoptosis. Med. Mycol. 2018, 56, 565–578. [Google Scholar] [CrossRef]
  17. Ai, Y.; Fang, F.; Zhang, L.; Liao, H. Antimicrobial Activity of Oregano Essential Oil and Resveratrol Emulsions Co-Encapsulated by Sodium Caseinate with Polysaccharides. Food Control 2022, 137, 108925. [Google Scholar] [CrossRef]
  18. Guimarães, A.C.; Meireles, L.M.; Lemos, M.F.; Guimarães, M.C.C.; Endringer, D.C.; Fronza, M.; Scherer, R. Antibacterial Activity of Terpenes and Terpenoids Present in Essential Oils. Molecules 2019, 24, 2471. [Google Scholar] [CrossRef] [Green Version]
  19. Yu, H.; Ren, X.; Yang, F.; Xie, Y.; Guo, Y.; Cheng, Y.; Yao, W. Antimicrobial and Anti-dust Mite Efficacy of Cinnamomum Camphora Chvar. Borneol Essential Oil Using Pilot-plant Neutral Cellulase-assisted Steam Distillation. Lett. Appl. Microbiol. 2022, 74, 258–267. [Google Scholar] [CrossRef]
  20. Zhou, H.; Tao, N.; Jia, L. Antifungal Activity of Citral, Octanal and α-Terpineol against Geotrichum citri-aurantii. Food Control 2014, 37, 277–283. [Google Scholar] [CrossRef]
  21. Mulyaningsih, S.; Sporer, F.; Zimmermann, S.; Reichling, J.; Wink, M. Synergistic Properties of the Terpenoids Aromadendrene and 1,8-Cineole from the Essential Oil of Eucalyptus globulus against Antibiotic-Susceptible and Antibiotic-Resistant Pathogens. Phytomedicine 2010, 17, 1061–1066. [Google Scholar] [CrossRef]
  22. Keymaram, M.; Falahati, M.; Farahyar, S.; Lotfali, E.; Abolghasemi, S.; Mahmoudi, S.; Sadeghi, F.; Khalandi, H.; Ghasemi, R.; Shamsaei, S.; et al. Anti-Biofilm Properties of Eucalyptol in Combination with Antifungals against Candida albicans Isolates in Patients with Hematological Malignancy. Arch. Microbiol. 2022, 204. [Google Scholar] [CrossRef]
  23. Al-Ghanayem, A.A. Phytochemical Analysis of Cymbopogon flexuosus (Lemongrass) Oil, Its Antifungal Activity, and Role in Inhibiting Biofilm Formation in Candida albicans MTCC854. J. King Saud Univ. Sci. 2022, 34, 102072. [Google Scholar] [CrossRef]
  24. D’Arrigo, M.; Bisignano, C.; Irrera, P.; Smeriglio, A.; Zagami, R.; Trombetta, D.; Romeo, O.; Mandalari, G. In Vitro Evaluation of the Activity of an Essential Oil from Pistacia vera L. Variety Bronte Hull against Candida Sp. BMC Complement. Altern. Med. 2019, 19, 6. [Google Scholar] [CrossRef]
  25. Sahal, G.; Woerdenbag, H.J.; Hinrichs, W.L.J.; Visser, A.; Tepper, P.G.; Quax, W.J.; van der Mei, H.C.; Bilkay, I.S. Antifungal and Biofilm Inhibitory Effect of Cymbopogon citratus (Lemongrass) Essential Oil on Biofilm Forming by Candida tropicalis Isolates; an in Vitro Study. J. Ethnopharmacol. 2020, 246, 112188. [Google Scholar] [CrossRef] [PubMed]
  26. Kojic, E.M.; Darouiche, R.O. Candida Infections of Medical Devices. Clin. Microbiol. Rev. 2004, 17, 255–267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mutlu-Ingok, A.; Devecioglu, D.; Dikmetas, D.N.; Karbancioglu-Guler, F.; Capanoglu, E. Antibacterial, Antifungal, Antimycotoxigenic, and Antioxidant Activities of Essential Oils: An Updated Review. Molecules 2020, 25, 4711. [Google Scholar] [CrossRef] [PubMed]
  28. Etxaniz, A.; González-Bullón, D.; Martín, C.; Ostolaza, H. Membrane Repair Mechanisms against Permeabilization by Pore-Forming Toxins. Toxins 2018, 10, 234. [Google Scholar] [CrossRef] [Green Version]
  29. Liao, S.; Yang, G.; Huang, S.; Li, B.; Li, A.; Kan, J. Chemical Composition of Zanthoxylum schinifolium Siebold & Zucc. Essential Oil and Evaluation of Its Antifungal Activity and Potential Modes of Action on Malassezia restricta. Ind. Crops Prod. 2022, 180, 114698. [Google Scholar] [CrossRef]
  30. Zore, G.B.; Thakre, A.D.; Rathod, V.; Karuppayil, S.M. Evaluation of Anti-Candida Potential of Geranium Oil Constituents against Clinical Isolates of Candida albicans Differentially Sensitive to Fluconazole: Inhibition of Growth, Dimorphism and Sensitization. Mycoses 2011, 54, e99–e109. [Google Scholar] [CrossRef]
  31. Ramage, G.; Milligan, S.; Lappin, D.F.; Sherry, L.; Sweeney, P.; Williams, C.; Bagg, J.; Culshaw, S. Antifungal, Cytotoxic, and Immunomodulatory Properties of Tea Tree Oil and Its Derivative Components: Potential Role in Management of Oral Candidosis in Cancer Patients. Front. Microbiol. 2012, 3. [Google Scholar] [CrossRef]
  32. Ding, Y.; Zhang, K.; Yin, Y.; Wu, J. D319 Induced Antifungal Effects through ROS-Mediated Apoptosis and Inhibited Isocitrate Lyase in Candida albicans. Biochim. Biophys. Acta Gen. Subj. 2022, 1866, 130050. [Google Scholar] [CrossRef] [PubMed]
  33. Yang, S.-K.; Yusoff, K.; Thomas, W.; Akseer, R.; Alhosani, M.S.; Abushelaibi, A.; Lim, S.-H.-E.; Lai, K.-S. Lavender Essential Oil Induces Oxidative Stress Which Modifies the Bacterial Membrane Permeability of Carbapenemase Producing Klebsiella pneumoniae. Sci. Rep. 2020, 10, 819. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Perrone, G.G.; Tan, S.-X.; Dawes, I.W. Reactive Oxygen Species and Yeast Apoptosis. Biochim. Biophys. Acta Mol. Cell Res. 2008, 1783, 1354–1368. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Čáp, M.; Váchová, L.; Palková, Z. Reactive Oxygen Species in the Signaling and Adaptation of Multicellular Microbial Communities. Oxid. Med. Cell. Longev. 2012, 2012, 976753. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Maurya, I.K.; Pathak, S.; Sharma, M.; Sanwal, H.; Chaudhary, P.; Tupe, S.; Deshpande, M.; Chauhan, V.S.; Prasad, R. Antifungal Activity of Novel Synthetic Peptides by Accumulation of Reactive Oxygen Species (ROS) and Disruption of Cell Wall against Candida albicans. Peptides 2011, 32, 1732–1740. [Google Scholar] [CrossRef] [PubMed]
  37. Souza, P.F.N.; Marques, L.S.M.; Oliveira, J.T.A.; Lima, P.G.; Dias, L.P.; Neto, N.A.S.; Lopes, F.E.S.; Sousa, J.S.; Silva, A.F.B.; Caneiro, R.F.; et al. Synthetic Antimicrobial Peptides: From Choice of the Best Sequences to Action Mechanisms. Biochimie 2020, 175, 132–145. [Google Scholar] [CrossRef] [PubMed]
  38. Oliveira, A.R.M.F.; Jezler, C.N.; Oliveira, R.A.; Mielke, M.S.E.; Costa, L.C.B. Determinação Do Tempo de Hidrodestilação e Do Horário de Colheita No Óleo Essencial de Menta. Hortic. Brasc 2012, 30, 155–159. [Google Scholar] [CrossRef] [Green Version]
  39. Clinical and Laboratory Standards Institute. M27-A3: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 3rd ed.; Approved Standard; Clinical and Laboratory Standards Institute: online, 2008. [Google Scholar]
  40. Oliveira, J.T.A.; Souza, P.F.N.; Vasconcelos, I.M.; Dias, L.P.; Martins, T.F.; Van Tilburg, M.F.; Guedes, M.I.F.; Sousa, D.O.B. Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII Are Synthetic Antimicrobial Peptides Active against Human Pathogens by Stimulating ROS Generation and Increasing Plasma Membrane Permeability. Biochimie 2019, 157, 10–21. [Google Scholar] [CrossRef]
  41. Dias, L.P.; Souza, P.F.N.; Oliveira, J.T.A.; Vasconcelos, I.M.; Araújo, N.M.S.; Tilburg, M.F.V.; Guedes, M.I.F.; Carneiro, R.F.; Lopes, J.L.S.; Sousa, D.O.B. RcAlb-PepII, a Synthetic Small Peptide Bioinspired in the 2S Albumin from the Seed Cake of Ricinus communis, Is a Potent Antimicrobial Agent against Klebsiella pneumoniae and Candida parapsilosis. Biochim. Biophys. Acta Biomembr. 2020, 1862, 183092. [Google Scholar] [CrossRef]
  42. Dikalov, S.I.; Harrison, D.G. Methods for Detection of Mitochondrial and Cellular Reactive Oxygen Species. Antioxid. Redox Signal. 2014, 20, 372–382. [Google Scholar] [CrossRef]
  43. Staniszewska, M.; Bondaryk, M.; Swoboda-Kopec, E.; Siennicka, K.; Sygitowicz, G.; Kurzatkowski, W. Candida albicans Morphologies Revealed by Scanning Electron Microscopy Analysis. Braz. J. Microbiol. 2013, 44, 813–821. [Google Scholar] [CrossRef] [PubMed]
Figure 1. C. blanchetianus in the field. (A) Many C. blanchetianus trees and (B) C. blanchetianus leaves used in the oil extraction.
Figure 1. C. blanchetianus in the field. (A) Many C. blanchetianus trees and (B) C. blanchetianus leaves used in the oil extraction.
Jof 08 01147 g001
Figure 2. Fluorescence images showing membrane damage and pore size on planktonic cells of C. albicans and C. parapsilosis. The membrane damage was assayed by propidium iodide (PI) uptake and pore size by using a 6 kDa dextran-FITC. The control was 5% DMSO. Bars indicates 100 µm.
Figure 2. Fluorescence images showing membrane damage and pore size on planktonic cells of C. albicans and C. parapsilosis. The membrane damage was assayed by propidium iodide (PI) uptake and pore size by using a 6 kDa dextran-FITC. The control was 5% DMSO. Bars indicates 100 µm.
Jof 08 01147 g002
Figure 3. Fluorescence images showing membrane damage and pore size on biofilm cells of C. albicans and C. parapsilosis. The membrane damage was assayed by propidium iodide (PI) uptake and pore size by using a 6 kDa FITC-Dextran. The control was 5% DMSO. Bars indicates 100 µm.
Figure 3. Fluorescence images showing membrane damage and pore size on biofilm cells of C. albicans and C. parapsilosis. The membrane damage was assayed by propidium iodide (PI) uptake and pore size by using a 6 kDa FITC-Dextran. The control was 5% DMSO. Bars indicates 100 µm.
Jof 08 01147 g003
Figure 4. Fluorescence images showing ROS overproduction (Green Fluorescence) by planktonic cells of C. albicans and C. parapsilosis. The control was 5% DMSO. White arrows indicate cell with green fluorescence. Bars indicates 100 µm.
Figure 4. Fluorescence images showing ROS overproduction (Green Fluorescence) by planktonic cells of C. albicans and C. parapsilosis. The control was 5% DMSO. White arrows indicate cell with green fluorescence. Bars indicates 100 µm.
Jof 08 01147 g004
Figure 5. Fluorescence images showing ROS overproduction (Green Fluorescence) by biofilm cells of C. albicans and C. parapsilosis. The control was 5% DMSO. White arrows indicate cells with green fluorescence. Bars indicates 100 µm.
Figure 5. Fluorescence images showing ROS overproduction (Green Fluorescence) by biofilm cells of C. albicans and C. parapsilosis. The control was 5% DMSO. White arrows indicate cells with green fluorescence. Bars indicates 100 µm.
Jof 08 01147 g005
Figure 6. Evaluation of apoptosis in C. albicans and C. parapsilosis strains under the action of CbEO at the concentration of 50 μg mL−1. Bars indicates 100 µm.
Figure 6. Evaluation of apoptosis in C. albicans and C. parapsilosis strains under the action of CbEO at the concentration of 50 μg mL−1. Bars indicates 100 µm.
Jof 08 01147 g006
Figure 7. Evaluation of apoptosis in C. albicans and C. parapsilosis biofilms under the action of CbEO at the concentration of 50 μg mL−1. Bars indicates 100 µm.
Figure 7. Evaluation of apoptosis in C. albicans and C. parapsilosis biofilms under the action of CbEO at the concentration of 50 μg mL−1. Bars indicates 100 µm.
Jof 08 01147 g007
Figure 8. Scanning electron microscopy of C. albicans and C. parapsilosis cells after the action of CbEO at the concentration of 50 μg mL−1. Magnification 10,000×.
Figure 8. Scanning electron microscopy of C. albicans and C. parapsilosis cells after the action of CbEO at the concentration of 50 μg mL−1. Magnification 10,000×.
Jof 08 01147 g008
Table 1. Compounds identified in essential oil from C. blanchetianus leaves (CbEO).
Table 1. Compounds identified in essential oil from C. blanchetianus leaves (CbEO).
CompoundRetention TimeArea (%)
limonene6.020.61
eucalyptol6.145.62
borneol9.840.64
terpinen-4-ol10.131.32
α-terpineol10.521.16
myrtenol10.700.70
δ-elemene14.610.46
α-ylangene15.670.51
β-bourbonene15.920.95
sativene16.151.99
E-caryophyllene16.861.95
aromadendrene17.370.56
6,9-guaiadiene17.471.31
α-humulene17.750.73
alloaromadendrene17.951.10
germacrene D18.470.57
γ-himachalene18.610.70
bicyclogermacrene18.900.57
δ-amorphene19.545.92
spathulenol21.081.49
caryophylleneoxide21.1620.03
epi- α-muurolol22.795.81
4.55
2.98
Table 2. Evaluation of CbEO on planktonic cells and biofilm formation of some microorganisms.
Table 2. Evaluation of CbEO on planktonic cells and biofilm formation of some microorganisms.
CbEO (50 µg mL−1)
Antifungal activity
Inhibition of planktonic cells growth (%)Inhibition of biofilm formation (%)Biomass reduction of preformed biofilm (%)Nystatin
C. albicans ATCC 1023178.55 ± 0.344.12 ± 0.2 41.12 ± 0.485.75 ± 0.1
C. krusei ATCC 62589.58 ± 0.500.0000.0075.00 ± 0.6
C. parapsilosis ATCC 2201975.94 ± 0.174.13 ± 0.727.75 ± 0.886.66 ± 0.3
C. tropicalis clinical isolate00.0000.0000.0093.85 ± 0.9
C. neoformans ATCC 3204500.0000.0000.0075.02 ± 0.5
Antibacterial activityCiprofloxacin
B. subtilis ATCC 663323.00 ± 0.300.0000.0085.42 ± 0.4
E. aerogenes ATCC 1304800.0000.0000.0084.23 ± 0.4
K. pneumoniae ATCC 1003100.0000.0000.0081.68 ± 0.7
P. aeruginosa ATCC 2561927.01 ± 0.700.0000.0087.39 ± 0.8
S. enterica ATCC 1402828.12 ± 0.500.0000.0087.74 ± 0.2
Table 3. Hemolytic activity of CbEO against different human red blood cells.
Table 3. Hemolytic activity of CbEO against different human red blood cells.
Blood Type Hemolysis (%)
0.1% Triton5% DMSOCbEO 250 µg mL−1CbEO 150 µg mL−1CbEO 100 µg mL−1CbEO 50 µg mL−1CbEO 25 µg mL−1
Type A100000v00
Type B100000000
Type O1000230000
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Malveira, E.A.; Souza, P.F.N.; Neto, N.A.S.; Aguiar, T.K.B.; Rodrigues, N.S.; Henrique, C.W.B.; Silva, A.F.B.; Lima, L.B.; Albuquerque, C.C.; Freitas, C.D.T. Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action. J. Fungi 2022, 8, 1147. https://doi.org/10.3390/jof8111147

AMA Style

Malveira EA, Souza PFN, Neto NAS, Aguiar TKB, Rodrigues NS, Henrique CWB, Silva AFB, Lima LB, Albuquerque CC, Freitas CDT. Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action. Journal of Fungi. 2022; 8(11):1147. https://doi.org/10.3390/jof8111147

Chicago/Turabian Style

Malveira, Ellen A., Pedro F. N. Souza, Nilton A. S. Neto, Tawanny K. B. Aguiar, Natanael S. Rodrigues, Carlos W. B. Henrique, Ayrles F. B. Silva, Leandro B. Lima, Cynthia C. Albuquerque, and Cleverson D. T. Freitas. 2022. "Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action" Journal of Fungi 8, no. 11: 1147. https://doi.org/10.3390/jof8111147

APA Style

Malveira, E. A., Souza, P. F. N., Neto, N. A. S., Aguiar, T. K. B., Rodrigues, N. S., Henrique, C. W. B., Silva, A. F. B., Lima, L. B., Albuquerque, C. C., & Freitas, C. D. T. (2022). Essential Oil from Croton blanchetianus Leaves: Anticandidal Potential and Mechanisms of Action. Journal of Fungi, 8(11), 1147. https://doi.org/10.3390/jof8111147

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop